These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 6224142)
41. Role of anaphylactic antibodies in immunity to schistosomes. Capron A; Dessaint JP; Capron M; Joseph M; Pestel J Am J Trop Med Hyg; 1980 Sep; 29(5):849-57. PubMed ID: 7435789 [TBL] [Abstract][Full Text] [Related]
42. The role of the eosinophil. Kay AB J Allergy Clin Immunol; 1979 Aug; 64(2):90-104. PubMed ID: 458057 [No Abstract] [Full Text] [Related]
44. Eosinophils as effector cells in disease. Spry CJ Schweiz Med Wochenschr; 1978 Oct; 108(41):1572-6. PubMed ID: 358387 [TBL] [Abstract][Full Text] [Related]
45. Effector and regulatory mechanisms in immunity to schistosomes: a heuristic view. Capron A; Dessaint JP Annu Rev Immunol; 1985; 3():455-76. PubMed ID: 2933049 [No Abstract] [Full Text] [Related]
46. Tetrapeptides of the eosinophil chemotactic factor of anaphylaxis (ECF-A) enhance eosinophil Fc receptor. Capron M; Capron A; Goetzl EJ; Austen KF Nature; 1981 Jan; 289(5793):71-3. PubMed ID: 7453810 [TBL] [Abstract][Full Text] [Related]
47. Selectivity of mediators released by eosinophils. Capron M; Tomassini M; Torpier G; Kusnierz JP; MacDonald S; Capron A Int Arch Allergy Appl Immunol; 1989; 88(1-2):54-8. PubMed ID: 2523359 [TBL] [Abstract][Full Text] [Related]
49. Effects of eosinophils on mast cells: a new pathway for the perpetuation of allergic inflammation. Piliponsky AM; Gleich GJ; Bar I; Levi-Schaffer F Mol Immunol; 2002 Sep; 38(16-18):1369. PubMed ID: 12217410 [TBL] [Abstract][Full Text] [Related]
50. Deposits of eosinophil granule proteins in cardiac tissues of patients with eosinophilic endomyocardial disease. Tai PC; Ackerman SJ; Spry CJ; Dunnette S; Olsen EG; Gleich GJ Lancet; 1987 Mar; 1(8534):643-7. PubMed ID: 2882081 [TBL] [Abstract][Full Text] [Related]
51. Eosinophil function. Butterworth AE; David JR N Engl J Med; 1981 Jan; 304(3):154-6. PubMed ID: 7003387 [No Abstract] [Full Text] [Related]
52. Ultrastructural evidence for release of major basic protein-containing crystalline cores of eosinophil granules in vivo: cytotoxic potential in Crohn's disease. Dvorak AM J Immunol; 1980 Jul; 125(1):460-2. PubMed ID: 6155407 [TBL] [Abstract][Full Text] [Related]
53. Immunologic aspects of host responses to schistosomiasis: resistance, immunopathology, and eosinophil involvement. Phillips SM; Colley DG Prog Allergy; 1978; 24():49-182. PubMed ID: 78498 [No Abstract] [Full Text] [Related]
55. [Cell biology and function of eosinophilic granulocytes in immunologic inflammation]. Kroegel C; Luttmann W; Zeck-Kapp G; Matthys H; Kapp A; Virchow JC Immun Infekt; 1994 Jun; 22(3):104-13. PubMed ID: 7927466 [TBL] [Abstract][Full Text] [Related]
56. Angiostrongylus cantonensis: role of eosinophils in the neurotoxic syndrome (Gordon-like phenomenon). Perez O; Capron M; Lastre M; Venge P; Khalife J; Capron A Exp Parasitol; 1989 May; 68(4):403-13. PubMed ID: 2721633 [TBL] [Abstract][Full Text] [Related]
57. Antigen-specific IgG and IgA, but not IgE, activate the effector functions of eosinophils in the presence of antigen. Muraki M; Gleich GJ; Kita H Int Arch Allergy Immunol; 2011; 154(2):119-27. PubMed ID: 20733320 [TBL] [Abstract][Full Text] [Related]
58. Intermediate molecular weight eosinophil chemotactic factors in rat peritoneal mast cells: immunologic release, granule association, and demostration of structura heterogeneity. Boswell RN; Austen KF; Goetzl EJ J Immunol; 1978 Jan; 120(1):15-20. PubMed ID: 24070 [No Abstract] [Full Text] [Related]